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journal homepage: www.e lsev ier .com/ locate /yse izLetter to the EditorWritten Declaration on Epilepsy No. 22/2011
The European Parliament,
– having regard to Rule 123 of its Rules of Procedure,
A. whereas epilepsy is the most common serious disorder of
the brain,
B. whereas 6 000 000 people in Europe have epilepsy, with
300 000 new cases diagnosed each year,
C. whereas up to 70% of people with epilepsy could be seizure-
free with appropriate treatment, while 40% of people with
epilepsy in Europe do not receive such treatment,
D. whereas 40% of children with epilepsy have difficulties at
school,
E. whereas people with epilepsy in Europe experience high
levels of unemployment,
F. whereas people with epilepsy are exposed to stigma and
prejudice,
G. whereas epilepsy damages health but also disrupts every
aspect of life, and can impose physical, psychological and
social burdens on individuals and families.
1. Calls on the Commission and Council to:
– encourage research and innovation in the area of prevention
and early diagnosis and treatment of epilepsy;
– prioritise epilepsy as a major disease that imposes a significant
burden across Europe;
– take initiatives to encourage Member States to ensure equal
quality of life, including in education, employment, transport
and public healthcare, for people with epilepsy, e.g. by stimu-
lating the exchange of best practice;
– encourage effective health impact assessments on all major EU
and national policies.
2. Calls on the Member States to introduce appropriate legisla-
tion to protect the rights of all people with epilepsy.
3. Instructs its President to forward this declaration, together
with the names of the signatories, to the Commission and the
Parliaments of the Member States.The Written Declaration on Epilepsy: An important achieve-
ment for Europe and beyond
On 15th September 2011, the EuropeanWritten Declaration on
Epilepsy was passed by the European Union (EU) Parliament. This
was a signiﬁcant moment for all people who have been ﬁghting
over the years for a just recognition of the importance of epilepsy in
the European political agenda. The whole process described below
included several months of concerted effort by Members of the
European Parliament (MEPs) and by Epilepsy Advocacy Europe
(EAE), a joint task force of the International League Against
Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).
ILAE and IBE member associations in Europe andmany individuals
also contributed greatly to the success of this initiative.
1. What is a European Written Declaration?
AWritten Declaration is a text of a maximum of 200 words on a
matter falling within the EU’s sphere of activities. MEPs can use
written declarations to launch or re-launch a debate on a subject
that comes within the EU’s remit.
A group of up to ﬁve MEPs can submit a Written Declaration by
presenting a text to be signed by their colleagues. If the Declaration
is signed by amajority of theMEPs, it is forwarded to the President,
who announces it in plenary session.
The Declaration is then forwarded to the institutions named in
the text (in the case of the Written Declaration on Epilepsy, this
was the EU Commission and the Governments of EU Member
States), together with the names of the signatories. It is also
included in the minutes of the EU Parliament sitting at which it is
announced.
2. How the Declaration on Epilepsy came about
Following on the success of the ﬁrst European Epilepsy Day,
launched in Strasbourg in February 2011, several MEPs with
special interest in epilepsy created the ‘‘European Advocates for
Epilepsy Working Group’’ chaired by Mr Gay Mitchell, MEP. The
four other MEP founding members were Nirj Deva, Marian Harkin,
Peter Skinner, and Angelika Werthmann. The ﬁrst activity of the
Advocates for Epilepsy Working Group was the submission of the
Written Declaration on Epilepsy in April 2011, which was done in
collaboration with the ILAE/IBE joint task force. The text of the
Declaration, which follows the strict template, is as follows:
3. The process
Written Declarations are printed, translated into each EU
ofﬁcial language and posted in a register at the European
Parliament. The register is public and is kept outside the entrance
to the Chambers in Strasbourg and Brussels during plenary1059-1311 2011 British Epilepsy Association. Published by Elsevier Ltd.
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Open access unsessions. Declarations are also published on the Parliament’s
website.
The Written Declaration on Epilepsy was ready for signing in
time for the May plenary session in Strasbourg. Thereafter MEPs
were able to sign it during the plenary sessions in Strasbourg in
June, July and September and during the June mini session in
Brussels. These sessions, usually lasting 4 days eachmonth, are the
only times when the books are open for signatures.
To have the Written Declaration carried requires the signature
of a majority of MEPs. With the total number of MEPs being 738,
this meant that the Declaration on Epilepsy had to achieve supportder CC BY-NC-ND license. 
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had not been received by the closing date of the Declaration, it
would then have lapsed.
4. The plan of action and the outcome
Having the support and advice ofMr. GayMitchell,MEP, and the
29 other members of the European Advocates for Epilepsy Group
was very important to us in identifying how best to encourage
MEPs to sign the Declaration. MEPs were encouraged to sign by
committed fellow MEPs and by the ILAE/IBE Joint Task Force, who
had representatives present in Strasbourg and Brussels when the
Declaration registers were open. Promotional materials – leaﬂets,
posters, and banners –were distributed toMEPs during the plenary
sessions, and personal meetings were set up with MEPs or their
assistants, during sessions. Additionally, ILAE and IBE member
associations in EU countries proved extremely helpful in contact-
ing and enlisting the support of MEPs from their countries, an
activity that played a vital part in having the declaration carried.
In the end, it was all very worthwhile. When the Declaration
closed on 15th September, the target threshold of 369 signatures
was actually surpassed, with a ﬁnal number of 459 MEPs
supporting the Declaration with their signature! This made the
Written Declaration on Epilepsy the one with the highest number
of signatures in the current EU term, and also the third highest
number for a health-related Declaration since records exist!
5. Whatwill aWritten Declaration on Epilepsymean for people
with epilepsy and their families?
At national level, the Declaration demonstrates that the EU
Parliament recognises the need for improved services for people
with epilepsy. The approval of this declaration is thus an important
mechanism for those who have epilepsy, their families, their
friends and their carers, as well as for individual ILAE and IBE
associations, to approach national governments and advocate for
improved allocation of resources to epilepsy care. There have
already examples of this occurring successfully not only in some
EU member states, but also in countries outside the EU.
Epilepsy research is grossly underfunded in the EU. TheWritten
Declaration thus also signals to the European Commission the need
to support research on the mechanisms of epilepsy and the
development of more effective treatments.
Equally, there is a need for a European-wide awareness
programme to address the stigma which affects all aspects of
the life of people with epilepsy, including legislation, schooling,
employment, and personal relationships. Meetings have already
been initiated with the Directorate General on Health and
Consumer Affairs (DG Sanco) and the Directorate General on
Researchwithin the European Commission, in order to discuss how
epilepsy can become a priority in their various EU research and
funding programmes.
With epilepsy now recognised as a health priority by theWorld
Health Organization (WHO), the Pan American Health Organiza-
tion (PAHO) and the US Institute of Medicine (IOM), theendorsement of the Written Declaration on Epilepsy by the
European Parliament has added a further key impetus to this
international effort.
ILAE and IBE, supported by the European Advocates for Epilepsy
Group in the EU Parliament, are nowworking towards the creation
of a comprehensive European programme to improve epilepsy
awareness, care and research. The approval of the Written
Declaration was the ﬁrst essential step in this direction.
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